These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
648 related articles for article (PubMed ID: 11251569)
61. [Bacterial resistance in acne? A meta-analysis of the controversy]. Alvarez-Sánchez M; Rodríguez-Ayala E; Ponce-Olivera RM; Tirado-Sánchez A; Arellano-Mendoza MI Cir Cir; 2016; 84(3):190-5. PubMed ID: 26738649 [TBL] [Abstract][Full Text] [Related]
62. Acne and Propionibacterium acnes. Bojar RA; Holland KT Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721 [TBL] [Abstract][Full Text] [Related]
63. Propionibacterium acnes, an emerging pathogen: from acne to implant-infections, from phylotype to resistance. Aubin GG; Portillo ME; Trampuz A; Corvec S Med Mal Infect; 2014 Jun; 44(6):241-50. PubMed ID: 24656842 [TBL] [Abstract][Full Text] [Related]
65. A comparative study of Cutibacterium (Propionibacterium) acnes clones from acne patients and healthy controls. Lomholt HB; Scholz CFP; Brüggemann H; Tettelin H; Kilian M Anaerobe; 2017 Oct; 47():57-63. PubMed ID: 28434779 [TBL] [Abstract][Full Text] [Related]
66. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%. Leyden JJ; Wortzman M; Baldwin EK Cutis; 2008 Dec; 82(6):417-21. PubMed ID: 19181031 [TBL] [Abstract][Full Text] [Related]
67. An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains. McDowell A; Barnard E; Nagy I; Gao A; Tomida S; Li H; Eady A; Cove J; Nord CE; Patrick S PLoS One; 2012; 7(7):e41480. PubMed ID: 22859988 [TBL] [Abstract][Full Text] [Related]
68. Activity of the novel macrolide BAL19403 against ribosomes from erythromycin-resistant Propionibacterium acnes. Dreier J; Amantea E; Kellenberger L; Page MG Antimicrob Agents Chemother; 2007 Dec; 51(12):4361-5. PubMed ID: 17923495 [TBL] [Abstract][Full Text] [Related]
69. A Myrtus communis extract enriched in myrtucummulones and ursolic acid reduces resistance of Propionibacterium acnes biofilms to antibiotics used in acne vulgaris. Feuillolay C; Pecastaings S; Le Gac C; Fiorini-Puybaret C; Luc J; Joulia P; Roques C Phytomedicine; 2016 Mar; 23(3):307-15. PubMed ID: 26969384 [TBL] [Abstract][Full Text] [Related]
70. Antibiotic susceptibility of Propionibacterium acnes isolated from orthopaedic implant-associated infections. Khassebaf J; Hellmark B; Davidsson S; Unemo M; Nilsdotter-Augustinsson Å; Söderquist B Anaerobe; 2015 Apr; 32():57-62. PubMed ID: 25541476 [TBL] [Abstract][Full Text] [Related]
71. Propionibacterium acnes and antimicrobial resistance in acne. Dessinioti C; Katsambas A Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353 [TBL] [Abstract][Full Text] [Related]
72. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Gibreel A; Kos VN; Keelan M; Trieber CA; Levesque S; Michaud S; Taylor DE Antimicrob Agents Chemother; 2005 Jul; 49(7):2753-9. PubMed ID: 15980346 [TBL] [Abstract][Full Text] [Related]
73. Susceptibility profiles of Propionibacterium acnes isolated from patients with acne vulgaris. Grech I J Glob Antimicrob Resist; 2014 Mar; 2(1):35-38. PubMed ID: 27873635 [TBL] [Abstract][Full Text] [Related]
74. Utilizing the photodynamic properties of curcumin to disrupt biofilms in Cutibacterium acnes: A promising approach for treating acne. Zheng N; Xie Y; Zhou M; Liu Y; Xu H; Zeng R; Wan C; Li M Photodiagnosis Photodyn Ther; 2024 Feb; 45():103928. PubMed ID: 38070633 [TBL] [Abstract][Full Text] [Related]
75. Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne. Coates P; Vyakrnam S; Ravenscroft JC; Stables GI; Cunliffe WJ; Leyden JJ; Johnson J; Eady EA; Cove JH Br J Dermatol; 2005 Dec; 153(6):1126-36. PubMed ID: 16307647 [TBL] [Abstract][Full Text] [Related]
76. [A comparison of biochemical and genetic classification of propionibacterium acnes strains isolated from skin lesions of patients with acne]. Kasprowicz A; Owczarek MM; Miedzobrodzki J; Białecka A Med Dosw Mikrobiol; 2012; 64(3):203-10. PubMed ID: 23285774 [TBL] [Abstract][Full Text] [Related]
77. Current issues in antimicrobial therapy for the treatment of acne. Leyden JJ J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():51-5. PubMed ID: 11843235 [TBL] [Abstract][Full Text] [Related]
78. Characterization of acne patients carrying clindamycin-resistant Cutibacterium acnes: A Japanese multicenter study. Nakase K; Aoki S; Sei S; Fukumoto S; Horiuchi Y; Yasuda T; Tanioka M; Sugai J; Huh WW; Kakuta M; Nomoto M; Shimada T; Watanabe M; Kobayashi M; Murakami S; Takeo C; Tsubouchi R; Hayashi N; Noguchi N J Dermatol; 2020 Aug; 47(8):863-869. PubMed ID: 32424832 [TBL] [Abstract][Full Text] [Related]
79. Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections. Nenoff P; Haustein UF; Hittel N Chemotherapy; 2004 Oct; 50(4):196-201. PubMed ID: 15452398 [TBL] [Abstract][Full Text] [Related]
80. Inhibition of neutrophil chemotactic factor production in comedonal bacteria by subminimal inhibitory concentrations of erythromycin. Akamatsu H; Kurokawa I; Nishijima S; Asada Y Dermatology; 1992; 185(1):41-3. PubMed ID: 1386264 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]